Read articles from Global

October 02, 2025 by dcjournal.com

Governments originally implemented smoking bans to protect individuals from secondhand smoke exposure, claiming health concerns. However, recent proposals to also ban vaping and nicotine pouches in public spaces suggest a hidden agenda of stigmatizing nicotine users. Despite lacking evidence of harm to bystanders, governments are enforcing unjust restrictions on these products. The comparison between cigarette smoke and e-cigarette vapor highlights the minimal risk posed by vapor. Policies should be evidence-based and respect personal liberties, rather than imposing unwarranted bans driven by moral panic. The true intention behind smoking bans seems to be controlling and marginalizing certain groups, rather than safeguarding public health.

October 02, 2025 by dcjournal.com

Governments originally implemented smoking bans to protect individuals from secondhand smoke exposure, claiming health concerns. However, recent proposals to also ban vaping and nicotine pouches in public spaces suggest a hidden agenda of stigmatizing nicotine users. Despite lacking evidence of harm to bystanders, governments are enforcing unjust restrictions on these products. The comparison between cigarette smoke and e-cigarette vapor highlights the minimal risk posed by vapor. Policies should be evidence-based and respect personal liberties, rather than imposing unwarranted bans driven by moral panic. The true intention behind smoking bans seems to be controlling and marginalizing certain groups, rather than safeguarding public health.

October 02, 2025 by bloomberglaw.com

Philip Morris USA Inc. successfully challenged FDA rules on cigarette labeling and advertising in court, citing the agency's failure to disclose important data during the rulemaking process. The judge ruled in favor of the plaintiffs, including cigarette manufacturers and retailers, stating that the FDA's lack of transparency prejudiced their participation in the process. The FDA's attempt to enhance public understanding of smoking risks through new warning labels was supported by the judge, who found the agency's approach compliant with legal requirements. The case highlights legal battles over tobacco regulation and the balance between public health communication and industry interests.

October 02, 2025 by planetofthevapes.co.uk

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has criticized the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) for making public registration for its COP11 conference in Geneva nearly impossible. Executive Coordinator Nancy Loucas called the process an "insane system" designed to exclude legitimate stakeholders. Requirements such as detailed documents, letters of intent, and CVs create unnecessary obstacles, while the applicant declaration effectively bars consumer advocacy groups. Loucas argues this reflects a long-standing pattern of exclusion within the WHO FCTC process.

October 02, 2025 by rttnews.com

A study led by Sulakshan Neupane at the University of Georgia, based on over 1.2 million CDC survey responses, found that exclusive e-cigarette users were 7% more likely to develop prediabetes compared to non-smokers, equal to about 7,000 additional cases per million users. Traditional smokers had a 15% higher risk, while dual users faced a 28% higher risk. Neupane warned that although e-cigarettes are marketed as a safer alternative, they may still contribute to long-term health problems such as prediabetes and diabetes.

October 02, 2025 by nature.com

Participants aged 18-35, including ENDS users and controls, underwent saliva and subgingival plaque collection. Periodontal screening was conducted using CPITN. Saliva was collected after rinsing with water. Puffing behavior was assessed, and VOC emissions were analyzed. Subgingival plaque samples were collected following HMP protocols. DNA isolation, amplicon sequencing, and taxonomic annotation were performed. Microbiome analysis included diversity assessment and beta diversity using Bray-Curtis distances. Functional profiling was done using Tax4Fun2. Salivary metabolomics were analyzed, and microbiome-metabolome functional connections explored. Network integration analysis using xMWAS was conducted. Statistical analyses were adjusted for demographic factors. The study aimed to understand oral microbiome responses to ENDS use and associated metabolomic changes.

October 02, 2025 by nature.com

Participants aged 18-35, including ENDS users and controls, underwent saliva and subgingival plaque collection. Periodontal screening was conducted using CPITN. Saliva was collected after rinsing with water. Puffing behavior was assessed, and VOC emissions were analyzed. Subgingival plaque samples were collected following HMP protocols. DNA isolation, amplicon sequencing, and taxonomic annotation were performed. Microbiome analysis included diversity assessment and beta diversity using Bray-Curtis distances. Functional profiling was done using Tax4Fun2. Salivary metabolomics were analyzed, and microbiome-metabolome functional connections explored. Network integration analysis using xMWAS was conducted. Statistical analyses were adjusted for demographic factors. The study aimed to understand oral microbiome responses to ENDS use and associated metabolomic changes.

October 01, 2025 by gfn.tv

Public health’s assault on vaping and safer nicotine products isn’t guided by evidence, it’s driven by fear, outrage, and a profound misunderstanding of risk. At GFN 2025 in Warsaw, David Zaruk, the “Risk-Monger,” reveals how emotion overrides science in policymaking. From the misuse of the Precautionary Principle to the denormalization of entire industries, Zaruk argues that activist zeal and WHO dogma have turned nicotine into a moral battleground, sacrificing harm reduction and leaving millions of smokers without safer options.

September 30, 2025 by filtermag.org

The upcoming COP11 in Geneva will address tobacco control policies with potential impacts on global public health. Concerns exist over the exclusion of THR advocates at previous conferences, affecting the discussions on harm reduction products such as vapes. The complex registration process for COP11 has attracted criticism, with fears of limited public participation. Despite resistance from the WHO, advocates aim to emphasize harm reduction benefits at the conference. Prominent countries like New Zealand have supported THR, indicating a hopeful shift in attitudes towards public health strategies. Advocates stress the need for the FCTC treaty to prioritize smoking-related harm and resist external influences for effective tobacco control.

September 30, 2025 by gfn.tv

Explore tobacco harm reduction at GFN through a candid interview with Brazilian consumer advocate Alexandro Lucian, who shares why this global event matters, the misinformation challenges in Brazil, and why education and accurate science are essential for safer nicotine choices. Learn how language barriers, anti‑vaping narratives, and limited local research shape public opinion—and how translating complex evidence into Portuguese helps counter myths.